Saralaya Hospitals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 14-12-2024
- Paid Up Capital ₹ 2.50 M
as on 14-12-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.20 Cr
as on 14-12-2024
- Revenue 54.79%
(FY 2022)
- Profit 94.65%
(FY 2022)
- Ebitda 76.04%
(FY 2022)
- Net Worth 78.98%
(FY 2022)
- Total Assets 15.16%
(FY 2022)
About Saralaya Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹1.20 Cr.
Vijayalaxmi, Kanaradi Saralaya, and Pradeep Saralaya serve as directors at the Company.
- CIN/LLPIN
U74999KA2017PTC107356
- Company No.
107356
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Saralaya Hospitals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Saralaya  | Managing Director | 23-Oct-2017 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijayalaxmi | Director | 23-Oct-2017 | Current |
| Kanaradi Saralaya | Director | 23-Oct-2017 | Current |
Financial Performance of Saralaya Hospitals.
Saralaya Hospitals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 54.79% increase. The company also saw a substantial improvement in profitability, with a 94.65% increase in profit. The company's net worth Soared by an impressive increase of 78.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saralaya Hospitals?
In 2019, Saralaya Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹11.97 M
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.96 Cr
- Canara Bank : 0.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 May 2021 | Canara Bank | ₹2.37 M | Open |
| 22 Jan 2020 | Syndicate Bank | ₹1.10 M | Open |
| 12 Sep 2019 | Syndicate Bank | ₹8.50 M | Open |
How Many Employees Work at Saralaya Hospitals?
Saralaya Hospitals has a workforce of 14 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saralaya Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saralaya Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.